Effects of bepridil and lidocaine on the intraventricular conduction in acutely ischaemic and infarcted canine myocardium

Naunyn-Schmiedeberg's Archives of Pharmacology
H HashimotoM Nakashima

Abstract

Effects of bepridil, an antiarrhythmic and antianginal drug, on intraventricular conduction in acutely ischaemic and infarcted myocardium were examined in anaesthetized dogs, and compared with those of lidocaine. Bepridil at doses of 2 and 5 mg/kg markedly prolonged the conduction time of a premature excitation induced by a ventricular stimulation in the infarcted zone. The effect of bepridil was dependent on a coupling time of the stimulation. Bepridil showed a marked effect at a coupling time of 150 ms, while it showed no significant effect at a prolonged coupling time of 1 s. In other words, the effect of bepridil was interval-dependent. Lidocaine showed a similar interval-dependent effect, but the effect of lidocaine at a longer coupling time was less than that of bepridil. The premature stimulation produced severely delayed conduction which resulted in reentrant beats. Bepridil blocked these conductions, thereby preventing reentrant beats. In contrast to the depressant effect of bepridil in the infarcted myocardium, bepridil prevented the prolongation of conduction time during acute ischaemia. The alternation of the ST-T complex during acute ischaemia which is also an important arrhythmogenic factor was also attenuated by ...Continue Reading

References

Nov 14, 1977·Biochimica Et Biophysica Acta·L M Hondeghem, B G Katzung
Apr 1, 1977·Circulation·M J Kleinfeld, J J Rozanski
Sep 1, 1986·Journal of Cardiovascular Pharmacology·J J LynchB R Lucchesi
Jul 1, 1981·Journal of Cardiovascular Pharmacology·E Winslow, K A Kane
Jan 1, 1980·Journal of Cardiovascular Pharmacology·K A Kane, E Winslow
Nov 1, 1982·Japanese Heart Journal·H HashimotoK Ogawa
Jan 1, 1984·British Journal of Pharmacology·T AnnoK Yamada
Nov 1, 1980·Journal of Molecular and Cellular Cardiology·K R Courtney
Jun 1, 1981·British Journal of Pharmacology·R J Marshall, A W Muir

❮ Previous
Next ❯

Citations

Jun 18, 2010·Journal of Cardiovascular Pharmacology·Richard L Verrier, Tuomo Nieminen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.

Cardiac Electrophysiology

Cardiac electrophysiology is the study of electrical activities of the heart and includes the assessment, diagnosis, and treatment of cardiac events. Find the latest research on cardiac electrophysiology here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.